Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells

被引:25
作者
Chisaki, K
Okuda, Y
Suzuki, S
Miyauchi, T
Soma, M
Ohkoshi, N
Sone, H
Yamada, N
Nakajima, T
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058576, Japan
[2] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan
关键词
eicosapentaenoic acid; endothelin-1; insulin; human endothelial cells;
D O I
10.1291/hypres.26.655
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
cis-Polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) are the major fatty acids contained in fish oil, and are known to affect the various physiological properties of cell membranes in humans. The present study investigated the effects of polyunsaturated fatty acids on endothelin-1 (ET-1) production in human umbilical vein endothelial cells (HUVECs) and on insulin activity. After addition of various concentrations of EPA, docosahexaenoic acid, arachidonic acid, or linoleic acid to a culture medium, the concentration of ET-1 was measured using ELISA, and that of ET-1 mRNA was determined by RT-PCR. The results showed that EPA had the strongest inhibitory effect (p<0.05) on both basal ET-1 production and ET-1 mRNA levels. In addition, insulin (1 mumol/l) markedly increased ET-1 production, and EPA also significantly decreased the effect induced by insulin. Pretreatment with Ca2+ chelator EGTA (1 mmol/l), NOS inhibitor L-NAME (300 mumol/l), or calmodulin antagonist W-7 (300 mumol/l) inhibited NO production by EPA (100 mumol/l), but these pretreatments had no effect on ET-1 production by EPA. These findings suggest that EPA reduces basal and insulin-enhanced ET-1 production by inhibiting ET-1 mRNA production. These effects of EPA may contribute to its vasorelaxant and anti-atherosclerotic effects.
引用
收藏
页码:655 / 661
页数:7
相关论文
共 45 条
[1]   EFFECT OF EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACIDS ON BLOOD-PRESSURE IN HYPERTENSION - A POPULATION-BASED INTERVENTION TRIAL FROM THE TROMSO STUDY [J].
BONAA, KH ;
BJERVE, KS ;
STRAUME, B ;
GRAM, IT ;
THELLE, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) :795-801
[2]   CHRONIC EXPOSURE OF CULTURED ENDOTHELIAL-CELLS TO EICOSAPENTAENOIC ACID POTENTIATES THE RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTOR(S) [J].
BOULANGER, C ;
SCHINI, VB ;
HENDRICKSON, H ;
VANHOUTTE, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) :176-180
[3]  
BROX JH, 1981, THROMB HAEMOSTASIS, V46, P604
[4]   FISH FOOD, FISH OIL AND CARDIOVASCULAR-DISEASE [J].
BURR, ML .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1992, 14 (1-2) :181-192
[5]  
CAO WB, 1994, CHINESE MED J-PEKING, V107, P822
[6]   ENDOTHELIUM AND GROWTH-FACTORS IN VASCULAR REMODELING OF HYPERTENSION [J].
DZAU, VJ ;
GIBBONS, GH .
HYPERTENSION, 1991, 18 (05) :S115-S121
[7]   EFFECTS OF OMEGA-3, OMEGA-6 AND OMEGA-9 FATTY-ACIDS ON VASCULAR SMOOTH-MUSCLE TONE [J].
ENGLER, MB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) :325-328
[8]   EFFECT OF OMEGA-3-FATTY-ACIDS, DOCOSAHEXAENOIC AND EICOSAPENTAENOIC, ON NOREPINEPHRINE-INDUCED CONTRACTIONS [J].
ENGLER, MB .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (05) :675-679
[9]   INSULIN STIMULATES ENDOTHELIN-1 SECRETION FROM HUMAN ENDOTHELIAL-CELLS AND MODULATES ITS CIRCULATING LEVELS IN-VIVO [J].
FERRI, C ;
PITTONI, V ;
PICCOLI, A ;
LAURENTI, O ;
CASSONE, MR ;
BELLINI, C ;
PROPERZI, G ;
VALESINI, G ;
DEMATTIA, G ;
SANTUCCI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :829-835
[10]   UNTITLED [J].
FERRI, C ;
DEMATTIA, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (05) :689-690